# SYMBYAX
> **NDA021520** · New Drug Application · Sponsor: LILLY · Approved 2003-12-24
## Drug
- **FDA Application Number:** NDA021520
- **Application type:** New Drug Application
- **Brand name:** SYMBYAX
- **Generic name:** Fluoxetine Hydrochloride
- **Active ingredients:** FLUOXETINE HYDROCHLORIDE; OLANZAPINE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** LILLY
- **First approval:** 2003-12-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021520)
---
*MORVS · CC0 1.0*